These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34288860)

  • 1. Ulcerative Heliotrope Rash in Antimelanoma Differentiation-Associated Gene 5 Dermatomyositis.
    Daugherty TT; Cheeley JT
    Cutis; 2021 May; 107(5):E5-E8. PubMed ID: 34288860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
    Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
    Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gottron Papules and Gottron Sign with Ulceration: A Distinctive Cutaneous Feature in a Subset of Patients with Classic Dermatomyositis and Clinically Amyopathic Dermatomyositis.
    Cao H; Xia Q; Pan M; Zhao X; Li X; Shi R; Zhou M; Ding X; Kuwana M; Zheng J
    J Rheumatol; 2016 Sep; 43(9):1735-42. PubMed ID: 27307530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-MDA5 dermatomyositis. Literature review].
    Castro-Molina SA; Méndez-Flores S
    Rev Med Inst Mex Seguro Soc; 2023 Jan; 61(1):99-105. PubMed ID: 36542793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.
    Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R
    J Rheumatol; 2017 Mar; 44(3):319-325. PubMed ID: 28089977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.
    Muro Y; Sugiura K; Akiyama M
    Clin Rev Allergy Immunol; 2016 Dec; 51(3):293-302. PubMed ID: 26100618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease characteristics and clinical outcomes of adults and children with anti-MDA-5 antibody-associated myositis: a prospective observational bicentric study.
    Dunga SK; Kavadichanda C; Gupta L; Naveen R; Agarwal V; Negi VS
    Rheumatol Int; 2022 Jul; 42(7):1155-1165. PubMed ID: 34050793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of clinical and immunological features between clinically amyopathic dermatomyositis and typical dermatomyositis].
    Gan YZ; Li YH; Zhang LH; Ma L; He WW; Jin YB; An Y; Li ZG; Ye H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1001-1008. PubMed ID: 33331305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.
    Pozharashka J; Dourmishev L; Rusinova D; Balabanova M; Miteva L
    Acta Dermatovenerol Croat; 2020 Aug; 28(2):120-122. PubMed ID: 32876041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis responds to rituximab therapy.
    Ge Y; Li S; Tian X; He L; Lu X; Wang G
    Clin Rheumatol; 2021 Jun; 40(6):2311-2317. PubMed ID: 33411136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acral Cutaneous Ulcerations and Livedo Reticularis with Rapidly Progressive Interstitial Lung Disease in Anti-MDA5 Antibody-Positive Classical Dermatomyositis.
    Wongjirattikarn R; Chaowattanapanit S; Choonhakarn C; So-Ngern A; Mahakkanukrauh A; Foocharoen C
    Case Rep Dermatol; 2020; 12(1):57-63. PubMed ID: 32308577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of Amyopathic Dermatomyositis associated with Interstitial Pulmonary Disease.
    Ugan Y; Sahin M; Dogru A; Bayram D; Ceyhan AM; Tunc SE
    Clin Ter; 2015; 166(6):253-5. PubMed ID: 26794813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review.
    Huang K; Vinik O; Shojania K; Yeung J; Shupak R; Nimmo M; Avina-Zubieta JA
    Rheumatol Int; 2019 Nov; 39(11):1971-1981. PubMed ID: 31375890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis.
    Matsushita T; Mizumaki K; Kano M; Yagi N; Tennichi M; Takeuchi A; Okamoto Y; Hamaguchi Y; Murakami A; Hasegawa M; Kuwana M; Fujimoto M; Takehara K
    Br J Dermatol; 2017 Feb; 176(2):395-402. PubMed ID: 27452897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease: report of two cases.
    Mehta AA; Paul T; Cb M; Haridas N
    BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33910791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Livedo Racemosa, Reticulated Ulcerations, Panniculitis and Violaceous Plaques in a 46-year-old Woman.
    Agulló A; Hinds B; Larrea M; Yanguas I
    Indian Dermatol Online J; 2018; 9(1):47-49. PubMed ID: 29441299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-MDA5-associated dermatomyositis.
    Gupta R; Kumar S; Gow P; Hsien-Cheng Chang L; Yen L
    Intern Med J; 2020 Apr; 50(4):484-487. PubMed ID: 32270621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of neuropsychiatry disorder in patients with anti-MDA5 antibody dermatomyositis: A case report.
    Xing Y; Liu C; Xu M; Zhao L; Kong X
    Heliyon; 2023 Dec; 9(12):e22935. PubMed ID: 38076042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
    Fujisawa T; Hozumi H; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
    J Rheumatol; 2019 Aug; 46(8):935-942. PubMed ID: 31092718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum KL-6 level is a prognostic marker in patients with anti-MDA5 antibody-positive dermatomyositis associated with interstitial lung disease.
    Ye Y; Fu Q; Wang R; Guo Q; Bao C
    J Clin Lab Anal; 2019 Oct; 33(8):e22978. PubMed ID: 31301087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.